Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Raynaud's phenomenon
ADR ID BADD_A03708
ADR Hierarchy
24      Vascular disorders
24.04      Arteriosclerosis, stenosis, vascular insufficiency and necrosis
24.04.03      Peripheral vasoconstriction, necrosis and vascular insufficiency
24.04.03.003      Raynaud's phenomenon
Description An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. [MeSH]
MedDRA Code 10037912
MeSH ID D011928
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Raynaud like disorder | Raynaud's disease | Raynaud's disease aggravated | Raynaud's phenomenon | Raynaud's phenomenon aggravated | Raynaud's syndrome | Raynaud-like disorder | Raynaud-like phenomena | Raynauds | Raynauds phenomena of feet | Raynauds' phen | Raynaud Disease | Cold Fingers, Hereditary | Raynaud's Disease | Raynauds Disease | Raynaud Phenomenon
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000220%
BADD_D00100Ambrisentan0.000301%
BADD_D00130Amphetamine--
BADD_D00165Aripiprazole0.000436%
BADD_D00178Atenolol--
BADD_D00180Atomoxetine0.000510%
BADD_D00181Atomoxetine hydrochloride--
BADD_D00263Betaxolol--
BADD_D00277Bisoprolol0.000785%
BADD_D00280Bleomycin--
BADD_D00281Bleomycin sulfate--
BADD_D00285Bosentan0.000361%
BADD_D00304Bromocriptine--
BADD_D00305Bromocriptine mesylate--
BADD_D00329Cabergoline0.019218%
BADD_D00349Capecitabine0.000246%
BADD_D00354Captopril--
BADD_D00364Carboplatin0.000168%
BADD_D00411Celiprolol--
BADD_D00474Cisplatin--
BADD_D00502Clonidine--
BADD_D00503Clonidine hydrochloride--
BADD_D00589Dasatinib0.000716%
BADD_D00680Dimethyl fumarate0.001280%
BADD_D00759Eltrombopag0.000229%
BADD_D00766Emtricitabine0.002800%
BADD_D00767Enalapril maleate--
BADD_D00768Enalaprilat--
BADD_D00788Epoprostenol0.000082%
BADD_D00846Ethosuximide0.006339%
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages
ADReCS-Target
ADR Term Drug Name Target